Initiation Setting and Persistence of Medications Affecting Cognition in Older Adults

Dan P. Ly, Annie W. Yang, Mei Leng, Catherine A. Sarkisian, Cheryl L. Damberg, John N. Mafi

ResearchPosted on rand.org May 14, 2026Published in: JAMA Network Open, Volume 9, No. 4, e2610234 (April 2026). DOI: 10.1001/jamanetworkopen.2026.10234

Medications that adversely affect cognition, eg, antipsychotics, may increase delirium and fall risk among older adults, but they remain frequently prescribed. To better understand the context of their prescribing, this study examined the clinical settings in which these medications were initiated and the rate at which patients continue to take them 1 year later. This cross-sectional study used Health and Retirement Study (HRS) data of community-dwelling adults aged 66 years or older linked to Medicare fee-for-service claims (including Part D prescription fills) between January 1, 2008, and December 31, 2021. The University of California, Los Angeles institutional review board approved the study with a waiver of informed consent as the data were deidentified. The study followed the STROBE reporting guideline for cross-sectional studies.

Topics

Document Details

  • Publisher: American Medical Association
  • Availability: Non-RAND
  • Year: 2026
  • Pages: 4
  • Document Number: EP-71287

Research conducted by

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.